Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now loads a 403 Forbidden error page, replacing the previous study record content. As a result, the detailed study information and related sections are no longer accessible.
    Difference
    20%
    Check dated 2026-09-19T19:25:19.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the previous Revision: v3.6.5 on the page, indicating a small update to the page’s metadata/UI.
    Difference
    0.0%
    Check dated 2026-08-29T20:26:57.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a minor system update. This does not change any study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-08T14:52:26.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a small update to the page’s version. It reflects a new version of the page content or layout without altering the study details presented.
    Difference
    0.0%
    Check dated 2026-07-25T08:24:11.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, signaling a slight update to the content or backend metadata without changing the displayed study information.
    Difference
    0.0%
    Check dated 2026-07-03T22:40:31.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.2, replacing v3.6.0. This indicates a backend or UI update without adding substantive study details.
    Difference
    0.0%
    Check dated 2026-06-27T00:30:49.000Z thumbnail image

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.